Department of Emergency and Critical Care Medicine, Tokyobay Urayasu Ichikawa Medical Center, Japan.
Department of General Internal Medicine, Tokyobay Urayasu Ichikawa Medical Center, Japan.
Intern Med. 2020 Oct 15;59(20):2619-2622. doi: 10.2169/internalmedicine.4488-20. Epub 2020 Jun 30.
Amiodarone, prescribed for cardiac conditions, including dysrhythmia, is associated with bradycardia. However, few reports have demonstrated that bradycardia is observed when amiodarone is used in combination with sofosbuvir, a direct-acting antiviral drug for chronic hepatitis C. We herein report the case of a male patient in his 70s with chronic atrial fibrillation and prostatic hyperplasia and was also taking amiodarone, who experienced severe bradycardia and syncope a day after taking sofosbuvir and ribavirin for chronic hepatitis C. After discontinuing amiodarone, ribavirin, and sofosbuvir, bradycardia did not recur. Therefore, we must consider drug interactions between amiodarone and sofosbuvir in patients with severe bradycardia.
胺碘酮,用于治疗心律失常等心脏疾病,与心动过缓有关。然而,很少有报道表明,当胺碘酮与直接作用的抗病毒药物索非布韦联合用于慢性丙型肝炎时,会观察到心动过缓。本文报告了一例 70 多岁的男性慢性心房颤动和前列腺增生患者,他还服用胺碘酮,在服用索非布韦和利巴韦林治疗慢性丙型肝炎一天后出现严重心动过缓和晕厥。停用胺碘酮、利巴韦林和索非布韦后,心动过缓未再复发。因此,我们必须考虑胺碘酮和索非布韦在严重心动过缓患者之间的药物相互作用。